Skip to content
10-Q

Quarterly Report

TECOGEN INC. TGEN

0001537435-25-000037

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 25.26M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $4.07M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $5.41M
Stockholders Equity Q1 2025 · Mar 31, 2025 $9.65M
Stockholders Equity Q1 2025 · Dec 31, 2024 $10.23M
Current Liabilities Q1 2025 · Mar 31, 2025 $14.95M
Current Liabilities Q1 2025 · Dec 31, 2024 $16.82M
Total Liabilities Q1 2025 · Mar 31, 2025 $20.21M
Total Liabilities Q1 2025 · Dec 31, 2024 $20.97M
Current Assets Q1 2025 · Mar 31, 2025 $20.61M
Current Assets Q1 2025 · Dec 31, 2024 $22.15M
Total Assets Q1 2025 · Dec 31, 2024 $31.09M
Total Assets Q1 2025 · Mar 31, 2024 $28.46M
Shares Diluted Q1 2025 · Mar 31, 2024 24.85M sh
Capex Q1 2025 · Mar 31, 2024 $104.95K
Operating Cash Flow Q1 2025 · Mar 31, 2024 $248.22K
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.04
Eps Basic Q1 2025 · Mar 31, 2024 −$0.04
Rd Expense Q1 2025 · Mar 31, 2024 $254.7K
Net Income Q1 2025 · Mar 31, 2024 −$1.1M
Operating Income Q1 2025 · Mar 31, 2024 −$1.05M
Gross Profit Q1 2025 · Mar 31, 2024 $2.58M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $3.61M
Revenue Q1 2025 · Mar 31, 2024 $6.19M